Year archive

Karolinska Development — 2013 filings

All 54 regulatory filings released by Karolinska Development (KDEV) in 2013, sourced directly from the official regulator.

54 Filings

2013 Period

2013 filings (54)

Filing	Released	Lang
Axelar rapporterar slutliga data från fas II-studie av AXL1717 vid lungcancer Legal Proceedings Report	2013-12-27	Swedish
Axelar announces final data from Phase II study with AXL1717 in lung cancer Earnings Release FY 2013	2013-12-27	English
Interim / Quarterly Report 2013 Interim / Quarterly Report 9M 2013	2013-11-21	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report 9M 2013	2013-11-21	English
Pergamum announces final data from Phase I/II study of LL-37 in patients with chronic leg ulcers Earnings Release FY 2013	2013-10-10	English
Pergamum rapporterar slutgiltigt resultat från fas I/II-studie med LL-37 på patienter med svårläkta bensår Earnings Release FY 2013	2013-10-10	Swedish
Lipidor rapporterar positiva kliniska fas I/II-data vid behandling av psoriasis Regulatory Filings	2013-08-27	Swedish
Lipidor reports positive clinical Phase I/II data in psoriasis Regulatory Filings	2013-08-27	English
Purchase of own shares to cover social security fees related to incentive program Transaction in Own Shares	2013-08-22	English
Återköp av egna aktier för att täcka sociala avgifter kopplade till incitamentsprogram Transaction in Own Shares	2013-08-22	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report H1 2013	2013-08-22	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report H2 2013	2013-08-22	English
Pharmanest meets all efficacy and safety end points in Phase II study of SHACT Regulatory Filings	2013-08-01	English
Pharmanest uppnår alla studiemål i fas II-studie av SHACT Regulatory Filings	2013-08-01	Swedish
Oss-Q completes financing, initiates clinical study and changes name to OssDsign Capital/Financing Update	2013-07-15	English
Oss-Q slutför finansiering, initierar klinisk studie och byter namn till OssDsign Share Issue/Capital Change	2013-07-15	Swedish
Pergamum reports positive preliminary efficacy results from a Phase I/II study of LL-37 in patients with chronic leg ulcers Earnings Release FY 2013	2013-07-04	English
Pergamum rapporterar positiva preliminära effektdata från en fas I/II-studie med LL-37 i patienter med svårläkta sår Earnings Release FY 2013	2013-07-04	Swedish
Karolinska Development initiates collaborations with Ospedale San Raffaele and Medical University of Graz Regulatory Filings	2013-06-27	English
Karolinska Development inleder samarbete med Ospedale San Raffaele och Medicinska universitetet i Graz Regulatory Filings	2013-06-27	Swedish
Karolinska Development invests in Forendo Pharma M&A Activity	2013-06-25	English
Karolinska Development investerar i Forendo Pharma M&A Activity	2013-06-25	Swedish
Athera and Boehringer Ingelheim enter into an option agreement on a novel therapy for Atherosclerosis M&A Activity	2013-06-19	English
Athera och Boehringer Ingelheim ingår optionsavtal för en innovativ terapi mot åderförkalkning M&A Activity	2013-06-19	Swedish
EU bidrar med 6 miljoner euro till den kliniska utvecklingen av Atheras antikroppsterapi mot hjärt-kärlsjukdom Capital/Financing Update	2013-06-17	Swedish
EU grants EUR 6m to the clinical development of Athera´s cardiovascular disease antibody therapy Capital/Financing Update	2013-06-17	English
Första patienten doserad i fas I/II-studie med Umecrine Moods läkemedelskandidat mot svåra premenstruella symtom Regulatory Filings	2013-05-23	Swedish
First patient dosed in the Phase I/II study of Umecrine Mood’s candidate drug for premenstrual dysphoric disorder Regulatory Filings	2013-05-23	English
Karolinska Developments årsstämma 2013 AGM Information	2013-05-15	Swedish
Karolinska Development´s Annual General Meeting 2013 AGM Information	2013-05-15	English
Interim / Quarterly Report 2013 Interim / Quarterly Report Q1 2013	2013-05-10	Swedish
Interim / Quarterly Report 2013 Interim / Quarterly Report Q1 2013	2013-05-10	English
Karolinska Development - Interim report January - March, invitation to conference call Friday, May 10 Report Publication Announcement	2013-05-07	English
Karolinska Development – Delårsrapport januari - mars, inbjudan till telefonkonferens fredagen den 10 maj Report Publication Announcement	2013-05-07	Swedish
Pergamum meddelar att alla patienter genomgått samtliga läkarbesök i en fas I/II-studie med en potentiell ny behandling av svårläkta sår Regulatory Filings	2013-04-19	Swedish
Pergamum announces last visit of last patient in a Phase I/II trial of a potential new treatment for hard-to-heal wounds Regulatory Filings	2013-04-19	English
Annual Report 2012 Annual Report FY 2012	2013-04-12	Swedish
Annual Report 2012 Annual Report FY 2012	2013-04-12	English
Notice of Annual General Meeting of Karolinska Development AB (publ) AGM Information	2013-04-11	English
Aktieägarna i Karolinska Development AB (publ) kallas till årsstämma AGM Information	2013-04-11	Swedish
Bo Jesper Hansen proposed as new Chairman of the Board Board/Management Information	2013-04-10	English
Bo Jesper Hansen föreslås som ny styrelseordförande Board/Management Information	2013-04-10	Swedish
Preliminary results of a Phase II study indicates that Axelar’s AXL1717 is efficacious in 2nd line treatment of patients with lung cancer Regulatory Filings	2013-04-02	English
Preliminära resultat från en fas II-studie indikerar att Axelars AXL1717 är effektiv i andrahandsbehandling av patienter med lungcancer Regulatory Filings	2013-04-02	Swedish
Karolinska Development and Rosetta Capital Announce the Closing of their SEK 220 Million Strategic Transaction M&A Activity	2013-03-08	English
Karolinska Development och Rosetta Capital annonserar slutförandet av strategisk affär värd 220 miljoner kronor M&A Activity	2013-03-08	Swedish
Earnings Release 2012 Earnings Release FY 2012	2013-02-20	Swedish
Interim / Quarterly Report 2012 Interim / Quarterly Report FY 2012	2013-02-20	English
Pergamum AB inleder strategiskt samarbete med Cadila Pharmaceuticals Ltd Regulatory Filings	2013-02-08	Swedish
Pergamum AB announces a strategic collaboration with Cadila Pharmaceuticals Ltd Regulatory Filings	2013-02-08	English
Karolinska Development startar samarbete med Mayo Clinic Regulatory Filings	2013-02-04	Swedish
Karolinska Development signs agreement with Mayo Clinic Regulatory Filings	2013-02-04	English
Dilaforette – Phase II study with sevuparin for the treatment of severe malaria initiated Regulatory Filings	2013-01-30	English
Dilaforette – Fas II-studie med sevuparin för behandling av svår malaria inledd Regulatory Filings	2013-01-30	Swedish

Filings by year

2026 19 filings
2025 20 filings
2024 25 filings
2023 18 filings
2022 26 filings
2021 41 filings
2020 40 filings
2019 187 filings
2018 34 filings
2017 66 filings
2016 42 filings
2015 53 filings
2014 55 filings
2013 54 filings
2012 40 filings
2011 41 filings